問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Taichung Veterans General Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
Division of Rheumatology
下載
2023-12-01 - 2026-12-28
Condition/Disease
Test Drug
Participate Sites2Sites
Not yet recruiting2Sites
2023-06-01 - 2026-06-08
xxxxxx
Dazodalibep
Participate Sites4Sites
Recruiting4Sites
2007-04-01 - 2011-12-31
Terminated4Sites
2021-10-01 - 2023-12-31
Participate Sites3Sites
Recruiting1Sites
2012-12-01 - 2014-12-31
Participate Sites5Sites
Terminated5Sites
2014-05-01 - 2020-12-31
Rheumatoid Arthritis
CNTO136 (sirukumab)
Study ended1Sites
2015-09-01 - 2020-05-31
Participate Sites7Sites
Terminated7Sites
2015-10-15 - 2020-06-30
Active Systemic Lupus Erythematosus
STELARA
Participate Sites6Sites
未分科
2010-06-01 - 2013-12-31
Participate Sites12Sites
Terminated12Sites
2015-08-01 - 2017-07-31
rheumatoid arthritis (RA) who had an inadequate response to DMARDs
ASP015K
Participate Sites11Sites
Terminated10Sites
全部
